299 related articles for article (PubMed ID: 30935657)
21. Flare changes after intravitreal injection of ocriplasmin in symptomatic vitreomacular traction syndrome.
Pirani V; Pelliccioni P; Cesari C; Carrozzi G; Cavallero E; Mariotti C
Jpn J Ophthalmol; 2019 May; 63(3):255-261. PubMed ID: 30805734
[TBL] [Abstract][Full Text] [Related]
22. The Portuguese Experience with Ocriplasmin in Clinical Practice.
Figueira J; Martins D; Pessoa B; Ferreira N; Meireles A; Sampaio A; Carneiro Â; Vaz F; Nascimento J; Moreno N; Roque J; Domingues M; Flores R; Teixeira C; Conde E; Henriques F; Proença H; Pita Negrão J; Barbosa M; Silva R; Vaz-Pereira S; Pereira Neves P; Gomes N; Raimundo M;
Ophthalmic Res; 2016; 56(4):186-192. PubMed ID: 27438077
[TBL] [Abstract][Full Text] [Related]
23. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome.
Singh RP; Li A; Bedi R; Srivastava S; Sears JE; Ehlers JP; Schachat AP; Kaiser PK
Br J Ophthalmol; 2014 Mar; 98(3):356-60. PubMed ID: 24357495
[TBL] [Abstract][Full Text] [Related]
24. Improvement in Patient-Reported Visual Function After Ocriplasmin for Vitreomacular Adhesion: Results of the Microplasmin for Intravitreous Injection-Traction Release Without Surgical Treatment (MIVI-TRUST) Trials.
Varma R; Haller JA; Kaiser PK
JAMA Ophthalmol; 2015 Sep; 133(9):997-1004. PubMed ID: 26068086
[TBL] [Abstract][Full Text] [Related]
25. LONGITUDINAL MICROPERIMETRY EVALUATION AFTER INTRAVITREAL OCRIPLASMIN INJECTION FOR VITREOMACULAR TRACTION.
Cacciamani A; Gelso A; Simonett JM; Ripandelli G; Pileri M; Stirpe M; Scarinci F
Retina; 2017 Oct; 37(10):1832-1838. PubMed ID: 28033236
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance.
Muqit MMK; Hamilton R; Ho J; Tucker S; Buck H
PLoS One; 2018; 13(5):e0197072. PubMed ID: 29768451
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials.
Haller JA; Stalmans P; Benz MS; Gandorfer A; Pakola SJ; Girach A; Kampik A; Jaffe GJ; Toth CA;
Ophthalmology; 2015 Jan; 122(1):117-22. PubMed ID: 25240630
[TBL] [Abstract][Full Text] [Related]
28. Ocriplasmin for treatment of vitreomacular traction and macular hole: A systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials.
Jackson TL; Haller J; Blot KH; Duchateau L; Lescrauwaet B
Surv Ophthalmol; 2022; 67(3):697-711. PubMed ID: 34480895
[TBL] [Abstract][Full Text] [Related]
29. Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications.
Chatziralli I; Theodossiadis G; Xanthopoulou P; Miligkos M; Sivaprasad S; Theodossiadis P
Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1247-56. PubMed ID: 27137631
[TBL] [Abstract][Full Text] [Related]
30. EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy.
Birch DG; Benz MS; Miller DM; Antoszyk AN; Markoff J; Kozma P; Meunier E; Sergott RC;
Retina; 2018 Feb; 38(2):364-378. PubMed ID: 28198785
[TBL] [Abstract][Full Text] [Related]
31. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study.
Greven MA; Garg S; Chiu B; Shah SP; Wolfe J; Fine HF; Roth DB; Robinson J; Mong J; Hsu J; Regillo C; Ho A; Haller JA
Br J Ophthalmol; 2016 Sep; 100(9):1211-5. PubMed ID: 26659344
[TBL] [Abstract][Full Text] [Related]
32. Does ocriplasmin affect the RPE-photoreceptor adhesion in macular holes?
Hager A; Seibel I; Riechardt A; Rehak M; Joussen AM
Br J Ophthalmol; 2015 May; 99(5):635-8. PubMed ID: 25403647
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes.
Sharma P; Juhn A; Houston SK; Fineman M; Chiang A; Ho A; Regillo C
Am J Ophthalmol; 2015 May; 159(5):861-7.e2. PubMed ID: 25660387
[TBL] [Abstract][Full Text] [Related]
34. Functional improvement assessed by multifocal electroretinogram after Ocriplasmin treatment for vitreomacular traction.
Rossi S; Testa F; Melillo P; Orrico A; Della Corte M; Simonelli F
BMC Ophthalmol; 2016 Jul; 16():110. PubMed ID: 27430356
[TBL] [Abstract][Full Text] [Related]
35. ASSESSMENT OF ANATOMICAL AND FUNCTIONAL OUTCOMES WITH OCRIPLASMIN TREATMENT IN PATIENTS WITH VITREOMACULAR TRACTION WITH OR WITHOUT MACULAR HOLES: Results of OVIID-1 Trial.
Tadayoni R; Holz FG; Zech C; Liu X; Spera C; Stalmans P
Retina; 2019 Dec; 39(12):2341-2352. PubMed ID: 30308558
[TBL] [Abstract][Full Text] [Related]
36. Ocriplasmin-Induced Macular Hole Closure in the Absence of Vitreomacular Adhesion Release.
Modi YS; Singh RP
Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):677-9. PubMed ID: 26114851
[TBL] [Abstract][Full Text] [Related]
37. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
[TBL] [Abstract][Full Text] [Related]
38. [Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole].
Lenk J; Matthé E; Ventzke S; Pillunat LE; Sandner D
Klin Monbl Augenheilkd; 2018 Jan; 235(1):73-80. PubMed ID: 28282697
[TBL] [Abstract][Full Text] [Related]
39. THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters.
Sadda SR; Dugel PU; Gonzalez VH; Meunier E; Kozma P
Retina; 2019 Feb; 39(2):319-330. PubMed ID: 29206755
[TBL] [Abstract][Full Text] [Related]
40. Effect of ocriplasmin on the management of macular holes: assessment of the clinical relevance of ocriplasmin.
Moisseiev J; Moroz I; Katz G
JAMA Ophthalmol; 2014 Jun; 132(6):709-13. PubMed ID: 24723009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
